What We're Reading - November EditionSubmitted by InFocus Financial Advisors, Inc. on October 30th, 2020
- Bloomberg - Current COVID-19 Vaccine Trial Progress
- A nice data driven piece on the status of current vaccine trials around the world. This includes the type, what they are and where they are in the stages to be approved.
- Morningstar - What is a "Neutral" portfolio?
- From Morningstar columnist John Rekenthaler, what determines a "neutral" portfolio allocation? We have been discussing this in-depth in our investment committee meetings. The answer, it depends.
- FactSet – Tracking the S&P500 Earnings Season
- Now almost through Q3 earnings reporting, how have companies fared so far? The good news is; better than expected. Nearly 86% of companies reporting have beaten their expected earnings reports for the last quarter.